| Literature DB >> 32778332 |
Armin Khosravipour1, Abdollah Amini2, Reza Masteri Farahani3, Fatemeh Zare4, Atarodsadat Mostafavinia5, Somaye Fallahnezhad6, Saman Akbarzade7, Mehrdad Asgari8, Ahmad Mohammadbeigi9, Fatemehsadat Rezaei10, Seyed Kamran Ghoreishi11, Sufan Chien12, Mohammad Bayat13.
Abstract
We assessed the combined impacts of human demineralized bone matrix (hDBM) scaffold, adipose-derived stem cells (hADS), and photobiomodulation (PBM) on bone repair of a critical size femoral defect (CSFD) in 72 rats. The rats were divided into six groups: control (group 1); ADS (group 2 - ADS transplanted into hDBM); PBM (group 3 - PBM-treated CSFDs); ADS + PBM in vivo (group 4 - ADS transplanted into hDBM and the CSFDs were treated with PBM in vivo); ADS + PBM in vitro (group 5 - ADS were treated with PBM in vitro, then seeded into hDBM); and ADS + PBM in vitro+in vivo (group 6 - PBM-treated ADS were seeded into hDBM, and the CSFDs were treated with PBM in vivo. At the anabolic phase (2 weeks after surgery), bone strength parameters of the groups 5, 6, and 4 were statistically greater than the control, ADS, and PBM in vivo groups (all, p = 0.000). Computed tomography (CT) scans during the catabolic phase (6 weeks after surgery) of bone healing revealed that the Hounsfield unit (HU) of CSFD in the groups 2 (p = 0.000) and 5 (p = 0.019) groups were statistically greater than the control group. The groups 5, 4, and 6 had significantly increased bone strength parameters compared with the PBM in vivo, control, and ADS groups (all, p = 0.000). The group 5 was statistically better than the groups 4, and 6 (both, p = 0.000). In vitro preconditioned of hADS with PBM significantly increased bone repair in a rat model of CSFD in vivo.Entities:
Keywords: Critical size bone defect; Demineralized bone scaffold; Fracture healing; Human adipose-derived stem cell; Photobiomodulation
Year: 2020 PMID: 32778332 DOI: 10.1016/j.bbrc.2020.07.048
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575